ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Erlotinib in Combination With Bortezomib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00895687
Recruitment Status : Completed
First Posted : May 8, 2009
Last Update Posted : July 13, 2015
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2015
  Study Completion Date : No date given